Study to Understand Risk Information to Support and Empower

NAEnrolling by invitationINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

April 13, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

February 28, 2026

Conditions
Diabetes, GestationalDiabetes Mellitus, Type 2
Interventions
BEHAVIORAL

Standard Health Information

Standard health information about postpartum screening and lifestyle programs for diabetes prevention

BEHAVIORAL

Values Affirmation (VA)

Interactive prompts to reflect on core personal values

BEHAVIORAL

Tailored Risk Information (TRI)

Interactive prompts to provide tailored information on risk factors for type 2 diabetes

BEHAVIORAL

Motivational Interviewing-based (MI)

Interactive prompts based on principles of motivational interviewing

BEHAVIORAL

Action planning (AP)

Interactive prompts to problem solve challenges

Trial Locations (1)

94588

Kaiser Permanente Northern California, Pleasanton

All Listed Sponsors
collaborator

Kaiser Foundation Research Institute

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of California, Davis

OTHER